Diceros Therapeutics, Inc. — Form D
Diceros Therapeutics, Inc. of NEWTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-30. The offering totals $16.7M, of which $6.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-09-30
- Form: D
- Accession: 0001948469-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $16.7M
- Amount sold: $6.7M
- Remaining: $10.0M
- Investors: 13
- Date of first sale: 2022-09-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-460347
Issuer
- Name: Diceros Therapeutics, Inc.
- CIK: 0001948469
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 275 GROVE STREET, 2-400, NEWTON, MA, 02466
- Phone: 617-663-5784
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Stephen R Seiler | Director | Newton, MA |
| Stephen R Seiler | Executive Officer | Newton, MA |
| Ids R van der Weij | Director | Newton, MA |
| Wyatt R Gotbetter | Director | Newton, MA |
| Jonathan R Fleming | Director | Newton, MA |
Other filings by this issuer (1)
More